222 related articles for article (PubMed ID: 26303991)
1. Anti-Pseudomonas aeruginosa IgY antibodies augment bacterial clearance in a murine pneumonia model.
Thomsen K; Christophersen L; Bjarnsholt T; Jensen PØ; Moser C; Høiby N
J Cyst Fibros; 2016 Mar; 15(2):171-8. PubMed ID: 26303991
[TBL] [Abstract][Full Text] [Related]
2. Azithromycin potentiates avian IgY effect against Pseudomonas aeruginosa in a murine pulmonary infection model.
Thomsen K; Christophersen L; Lerche CJ; Holmgaard DB; Calum H; Høiby N; Moser C
Int J Antimicrob Agents; 2021 Jan; 57(1):106213. PubMed ID: 33256950
[TBL] [Abstract][Full Text] [Related]
3. Anti-PcrV IgY antibodies protect against Pseudomonas aeruginosa infection in both acute pneumonia and burn wound models.
Ranjbar M; Behrouz B; Norouzi F; Mousavi Gargari SL
Mol Immunol; 2019 Dec; 116():98-105. PubMed ID: 31634816
[TBL] [Abstract][Full Text] [Related]
4. Anti-Pseudomonas aeruginosa IgY antibodies promote bacterial opsonization and augment the phagocytic activity of polymorphonuclear neutrophils.
Thomsen K; Christophersen L; Jensen PØ; Bjarnsholt T; Moser C; Høiby N
Hum Vaccin Immunother; 2016 Jul; 12(7):1690-9. PubMed ID: 26901841
[TBL] [Abstract][Full Text] [Related]
5. Anti-flagellin IgY antibodies protect against Pseudomonas aeruginosa infection in both acute pneumonia and burn wound murine models in a non-type-specific mode.
Ahmadi TS; Mousavi Gargari SL; Talei D
Mol Immunol; 2021 Aug; 136():118-127. PubMed ID: 34130152
[TBL] [Abstract][Full Text] [Related]
6. Passive immunization with anti- chimeric protein PilQ/PilA -DSL region IgY does not protect against mortality associated with Pseudomonas aeruginosa sepsis in a rabbit model.
Zamani K; Irajian G; Zahedi Bialvaei A; Zahraei Salehi T; Khormali M; Vosough A; Masjedian Jazi F
Mol Immunol; 2022 Jan; 141():258-264. PubMed ID: 34896925
[TBL] [Abstract][Full Text] [Related]
7. Bivalent flagellin immunotherapy protects mice against Pseudomonas aeruginosa infections in both acute pneumonia and burn wound models.
Ahmadi H; Behrouz B; Irajian G; Amirmozafari N; Naghavi S
Biologicals; 2017 Mar; 46():29-37. PubMed ID: 28065582
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy with IgY Antibodies toward Outer Membrane Protein F Protects Burned Mice against
Norouzi F; Behrouz B; Ranjbar M; Mousavi Gargari SL
J Immunol Res; 2020; 2020():7840631. PubMed ID: 32566689
[TBL] [Abstract][Full Text] [Related]
9. Augmented effect of early antibiotic treatment in mice with experimental lung infections due to sequentially adapted mucoid strains of Pseudomonas aeruginosa.
van Gennip M; Moser C; Christensen LD; Bjarnsholt T; Calum H; Jensen PØ; Christophersen L; Hougen HP; Ciofu O; Molin S; Givskov M; Høiby N
J Antimicrob Chemother; 2009 Dec; 64(6):1241-50. PubMed ID: 19815632
[TBL] [Abstract][Full Text] [Related]
10. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle.
Johansen HK; Cryz SJ; Hougen HP; Moser C; Høiby N
Behring Inst Mitt; 1997 Feb; (98):269-73. PubMed ID: 9382750
[TBL] [Abstract][Full Text] [Related]
11. Chicken IgY reduces the risk of
Schwartz FA; Christophersen L; Thomsen K; Baekdal S; Pals Bendixen M; Jørgensen M; Bull Rasmussen IK; Laulund AS; Høiby N; Moser C
Front Microbiol; 2022; 13():988386. PubMed ID: 36160201
[TBL] [Abstract][Full Text] [Related]
12. Anti-Pseudomonas aeruginosa IgY Antibodies Induce Specific Bacterial Aggregation and Internalization in Human Polymorphonuclear Neutrophils.
Thomsen K; Christophersen L; Bjarnsholt T; Jensen PØ; Moser C; Høiby N
Infect Immun; 2015 Jul; 83(7):2686-93. PubMed ID: 25895968
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Rhesus Theta-Defensin-1 in Experimental Models of Pseudomonas aeruginosa Lung Infection and Inflammation.
Bensman TJ; Jayne JG; Sun M; Kimura E; Meinert J; Wang JC; Schaal JB; Tran D; Rao AP; Akbari O; Selsted ME; Beringer PM
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559270
[TBL] [Abstract][Full Text] [Related]
14. Good effect of IgY against Pseudomonas aeruginosa infections in cystic fibrosis patients.
Nilsson E; Larsson A; Olesen HV; Wejåker PE; Kollberg H
Pediatr Pulmonol; 2008 Sep; 43(9):892-9. PubMed ID: 18680179
[TBL] [Abstract][Full Text] [Related]
15. Intranasal Peptide-Based FpvA-KLH Conjugate Vaccine Protects Mice From
Sen-Kilic E; Blackwood CB; Boehm DT; Witt WT; Malkowski AC; Bevere JR; Wong TY; Hall JM; Bradford SD; Varney ME; Damron FH; Barbier M
Front Immunol; 2019; 10():2497. PubMed ID: 31708925
[No Abstract] [Full Text] [Related]
16. IV Immunoglobulin for Acute Lung Injury and Bacteremia in Pseudomonas aeruginosa Pneumonia.
Katoh H; Yasumoto H; Shimizu M; Hamaoka S; Kinoshita M; Akiyama K; Sawa T
Crit Care Med; 2016 Jan; 44(1):e12-24. PubMed ID: 26317571
[TBL] [Abstract][Full Text] [Related]
17. Enhanced efficacy of the engineered antimicrobial peptide WLBU2 via direct airway delivery in a murine model of Pseudomonas aeruginosa pneumonia.
Chen C; Deslouches B; Montelaro RC; Di YP
Clin Microbiol Infect; 2018 May; 24(5):547.e1-547.e8. PubMed ID: 28882728
[TBL] [Abstract][Full Text] [Related]
18. Protease inhibitors elicit anti-inflammatory effects in CF mice with Pseudomonas aeruginosa acute lung infection.
Sandri A; Lleo MM; Signoretto C; Boaretti M; Boschi F
Clin Exp Immunol; 2021 Jan; 203(1):87-95. PubMed ID: 32946591
[TBL] [Abstract][Full Text] [Related]
19. Aerosol treatment with MNEI suppresses bacterial proliferation in a model of chronic Pseudomonas aeruginosa lung infection.
Woods DE; Cantin A; Cooley J; Kenney DM; Remold-O'Donnell E
Pediatr Pulmonol; 2005 Feb; 39(2):141-9. PubMed ID: 15633200
[TBL] [Abstract][Full Text] [Related]
20. [Long-term effect of erythromycin therapy on Pseudomonas aeruginosa in chronic murine model of pseudomonas pulmonary infection].
Nagata T; Mukae H; Kadokawa T; Kaida H; Kuroki M; Yanagihara K; Asano K; Kadota J; Koji T; Kawano S
Jpn J Antibiot; 2003 Apr; 56 Suppl A():57-9. PubMed ID: 14679749
[No Abstract] [Full Text] [Related]
[Next] [New Search]
